Table 2.
Evaluation of self-questionnaires and results of MoCA of patients presenting to the neurological post-COVID-19 outpatient clinic.
| Total | Female | Male | |
|---|---|---|---|
| ESS (mean; 0–24 points; n = 92) | 8.6 | 8.3 | 9.2 |
| - Normal daytime sleepiness (0–10 points) | 61 (66.3%) | 43 (67.2%) | 18 (64.3%) |
| - Mild to moderate excessive daytime sleepiness (11–15 points) | 25 (27.2%) | 17 (26.5%) | 8 (28.6%) |
| - Severe excessive daytime sleepiness (16–24 points) | 6 (6.5%) | 4 (6.3%) | 2 (7.1%) |
| BDI (mean; 0–63 points; n = 91) | 13.5 | 14.1 | 12.3 |
| - No depression (0–9 points) | 35 (38.5%) | 22 (34.9%) | 13 (46.4%) |
| - Mild depression (10–19 points) | 34 (37.4%) | 25 (39.7%) | 9 (32.1%) |
| - Moderate depression (20–29 points) | 17 (18.7%) | 11 (17.5%) | 6 (21.4%) |
| - Severe depression (30–63) | 5 (5.5%) | 5 (7.9%) | 0 |
| FSS (mean; 1–7 points; n = 91) | 5.0 | 5.1 | 4.7 |
| - No impairment due to fatigue (1–3 points) | 18 (19.8%) | 13 (20.3%) | 5 (18.5%) |
| - Impairment due to fatigue (4–7 points) | 73 (80.2%) | 51 (79.7%) | 22 (81.5%) |
| MoCA (mean; 0–30 points; n = 72) | 26.7 | 26.9 | 26.3 |
| - Normal (26–30 points) | 50 (69.4%) | 32 (71.1%) | 18 (66.7%) |
| - Pathologic (≤ 25 points) | 22 (30.6%) | 13 (28.9%) | 9 (33.3%) |